1-(3-Fluorobenzyl)-2-(piperidin-4-ylmethoxy)-1H-benzo[d]imidazole hydrochloride
95%
- Product Code: 186504
CAS:
1417792-99-4
| Molecular Weight: | 375.87 g./mol | Molecular Formula: | C₂₀H₂₃ClFN₃O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD22631652 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, inert gas |
Product Description:
Used primarily in pharmaceutical research as a key intermediate in the synthesis of selective kinase inhibitors. It shows particular relevance in the development of compounds targeting receptor tyrosine kinases involved in cancer cell proliferation and angiogenesis. Its structure supports high binding affinity to specific enzyme active sites, making it valuable in optimizing drug candidates for oncology. Additionally, it has been explored in the design of central nervous system agents due to its ability to cross the blood-brain barrier, offering potential in treating neurodegenerative diseases and psychiatric disorders. The compound's fluorobenzyl and benzimidazole moieties contribute to metabolic stability and enhanced bioavailability in preclinical studies.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 100mg | 10-20 days | $384.25 |
+
-
|
1-(3-Fluorobenzyl)-2-(piperidin-4-ylmethoxy)-1H-benzo[d]imidazole hydrochloride
Used primarily in pharmaceutical research as a key intermediate in the synthesis of selective kinase inhibitors. It shows particular relevance in the development of compounds targeting receptor tyrosine kinases involved in cancer cell proliferation and angiogenesis. Its structure supports high binding affinity to specific enzyme active sites, making it valuable in optimizing drug candidates for oncology. Additionally, it has been explored in the design of central nervous system agents due to its ability to cross the blood-brain barrier, offering potential in treating neurodegenerative diseases and psychiatric disorders. The compound's fluorobenzyl and benzimidazole moieties contribute to metabolic stability and enhanced bioavailability in preclinical studies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :